Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-01 Sale | 2023-02-01 9:41 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 8,448 | $0.25 | $2,112 | 66,082 (Direct) | View |
| 2023-01-31 Sale | 2023-01-31 9:51 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 7,240 | $0.241 | $1,745 | 192,030 (Direct) | View |
| 2022-02-01 Sale | 2022-02-01 9:20 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 6,730 | $6.573 | $44,236 | 564,270 (Direct) | View |
| 2020-04-14 Purchase | 2020-04-15 5:14 pm | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 21,000 | $4.6997 | $98,694 | 21,000 (Direct) | View |
| 2019-11-19 Sale | 2019-11-21 4:07 pm | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $62 | $465,000 | 63,833 (Direct) | View |
| 2019-11-12 Sale | 2019-11-13 4:30 pm | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $55 | $412,500 | 71,333 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-15 Option Award | 2024-07-17 12:28 pm | N/A 2034-07-14 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 64,262 | $0 | 265,581 (Direct) | View |
| 2024-07-15 Tax Withholding | 2024-07-17 12:28 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 749 | $64.25 | 265,581 (Direct) | View |
| 2024-06-04 Disposition | 2024-06-04 5:31 pm | N/A N/A | Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director | 222,011 | $0 | 0 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-22 1:04 pm | N/A 2034-01-17 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 21,843 | $0 | 21,843 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:00 pm | N/A 2033-07-13 | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 29,943 | $0 | 222,343 (Direct) | View |
| 2023-06-05 Option Award(A) | 2023-06-21 4:00 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 192,400 | $0 | 192,400 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-14 5:05 pm | N/A 2033-06-13 | Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-05 Option Award | 2023-06-07 2:00 pm | N/A N/A | INCYTE CORP | INCY | CAGNONI PABLO J President, R&D | 179,613 | $0 | 179,613 (Direct) | View |
| 2023-01-29 Exercise | 2023-01-31 9:51 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Director | 46,250 | $0 | 192,030 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-22 7:05 pm | N/A 2032-06-13 | Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-04-26 Ownership | 2022-02-14 7:52 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 6,200 | $0 | 29,320 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 9:20 pm | N/A 2032-01-30 | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 465,000 | $0 | 564,270 (Direct) | View |
| 2022-01-29 Exercise | 2022-02-01 9:20 pm | N/A N/A | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 21,250 | $0 | 564,270 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 4:13 pm | N/A 2031-06-03 | Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:26 pm | N/A 2031-01-28 | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J CEO and President | 460,000 | $0 | 460,000 (Direct) | View |
Ownership | 2020-10-15 5:02 pm | N/A N/A | TURMERIC ACQUISITION CORP. | TMPM | CAGNONI PABLO J Director | 0 | $0 | 25,000 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-30 06:36 am | N/A 2030-06-18 | Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2020-06-25 8:00 pm | N/A 2029-12-01 | Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director | 0 | $0 | 141,011 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-03 9:48 pm | N/A 2030-01-30 | Rubius Therapeutics Inc. | RUBY | CAGNONI PABLO J Chief Executive Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2019-11-19 Exercise | 2019-11-21 4:07 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $5.59 | 63,833 (Direct) | View |
| 2019-11-19 Exercise | 2019-11-21 4:07 pm | N/A 2025-11-04 | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $0 | 63,833 (Direct) | View |
| 2019-11-12 Exercise | 2019-11-13 4:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $5.59 | 71,333 (Direct) | View |
| 2019-11-12 Exercise | 2019-11-13 4:30 pm | N/A 2025-11-04 | CRISPR Therapeutics AG | CRSP | CAGNONI PABLO J Director | 7,500 | $0 | 71,333 (Direct) | View |